Moleculin Biotech Inc. (NASDAQ: MBRX) Stock Information | RedChip

Moleculin Biotech Inc. (NASDAQ: MBRX) Listen to this Section


$2.42
+0.1850 ( +8.30% ) 76.9K

Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of highly resistant tumors and viruses. The company's lead program, Annamycin is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.

Market Data


Open


$2.42

Previous close


$2.23

Volume


76.9K

Market cap


$6.25M

Day range


$1.48 - $2.44

52 week range


$1.48 - $15.75

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 37 Apr 25, 2024
8-k 8K-related 16 Apr 18, 2024
8-k 8K-related 18 Apr 10, 2024
8-k 8K-related 15 Apr 08, 2024
8-k 8K-related 17 Mar 27, 2024
8-k 8K-related 17 Mar 25, 2024
8-k 8K-related 38 Mar 25, 2024
8-k 8K-related 16 Mar 22, 2024
10-k Annual reports 70 Mar 22, 2024
8-k 8K-related 17 Mar 20, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.